Vaginal bleeding that happens 12 or more months after your final period is never normal, and it always needs to be checked — even one spot, even once, even if it stops on its own. The reassuring part is that roughly 90% of the time the cause turns out to be benign, most often a thin, fragile endometrium or vaginal atrophy from low oestrogen. The unreassuring part is the other 10%: in pooled data across dozens of studies, about 9% of women with postmenopausal bleeding are found to have endometrial cancer. That cancer is one of the most curable there is when it's caught while it's still confined to the uterus — which is precisely why bleeding cannot be waited out.
This article is written for the woman who has already Googled once, been half-reassured, and is now wondering whether it's worth "bothering" anyone. It is. Read the numbers and decide from there.
What counts as postmenopausal bleeding?
Menopause is defined retrospectively: it's the point 12 consecutive months after your last menstrual period. Anything that comes out of the vagina as blood after that milestone is postmenopausal bleeding, regardless of quantity or duration.
- A single streak of pink or brown on toilet paper.
- Spotting that lasts a day and never returns.
- Bleeding only after sex.
- A watery, pink or blood-tinged discharge — this counts too, and is easy to dismiss as "just discharge."
- A bleed that looks exactly like an old period ("I thought it had come back").
All of it needs assessment. If you are still in perimenopause — periods erratic but not yet 12 months gone — the rules are different and irregular bleeding is common; see irregular periods in perimenopause. If you're unsure which side of the line you're on, the menopause stage quiz can help you work it out, but when in doubt, get seen.
What actually causes bleeding after menopause?
Frequencies vary between studies and depend heavily on the population (age, HRT use, whether the clinic is a fast-track cancer service). The figures below are rough, honest orders of magnitude rather than precise statistics.
| Cause | Roughly how often | What it feels like / other clues |
|---|---|---|
| Endometrial atrophy (thin, fragile uterine lining) | The single most common finding — around half of cases in many series | Light spotting, often intermittent; no pain |
| Vaginal / vulvar atrophy (genitourinary syndrome of menopause) | Very common, often alongside endometrial atrophy | Dryness, burning, bleeding after sex, urinary symptoms |
| Endometrial polyps | Roughly 1 in 5 to 1 in 3 | Intermittent spotting; usually benign but removed and examined |
| Endometrial hyperplasia (thickened lining, sometimes pre-cancerous) | Around 5-10% | May be heavier bleeding; higher risk with obesity, PCOS history, tamoxifen |
| Endometrial (womb) cancer | About 9-10% | Bleeding is the first and often only symptom in ~90% of cases |
| HRT-related bleeding | Common in HRT users, especially in the first 3-6 months | Often expected early on — but see the section below |
| Cervical causes (polyps, ectropion, cervicitis, rarely cervical cancer) | A few percent | Classically bleeding after sex |
| Fibroids | Less common as a cause after menopause (they usually shrink) | Pressure, bulk symptoms; new growth after menopause needs assessment |
| Infection (endometritis, vaginitis) | Uncommon | Discharge, odour, discomfort |
Note what that table does and doesn't say. It says most postmenopausal bleeding is benign. It does not say your bleeding is benign — that distinction can only be made by examining you, not by reading a probability.
How likely is cancer, really?
A large 2018 pooled analysis in JAMA Internal Medicine looked at 129 studies and found endometrial cancer in about 9% of women presenting with postmenopausal bleeding. From the other direction: around 90% of women eventually diagnosed with endometrial cancer had postmenopausal bleeding as their presenting symptom. Bleeding is, in effect, the disease raising its hand early.
That early warning is worth an enormous amount. Endometrial cancer confined to the uterus at diagnosis has a five-year relative survival around 95%; once it has spread to distant sites, that figure collapses to roughly 20%. Very little in medicine offers that big a return on acting quickly. The risk is higher, not lower, if you have a higher body weight, diabetes, a history of PCOS or long stretches of unopposed oestrogen, took tamoxifen, or have Lynch syndrome in the family — but plenty of women with endometrial cancer have none of those.
What does the workup involve?
The point of the assessment is to answer one question: is the lining of your uterus normal? Most pathways look like this.
- History and examination. A speculum exam looks at the vulva, vagina and cervix — a surprising number of "uterine" bleeds turn out to be a cervical polyp or a fragile atrophic vaginal wall. Expect a cervical screening test if you're due one, but be clear about what that is and isn't: cervical screening (the smear or Pap test) looks for cell changes on the cervix. It is not a test for womb cancer, a normal result does not rule out endometrial cancer, and there is no routine screening test for endometrial cancer in the general population — which is exactly why the bleeding itself has to be investigated.
- Transvaginal ultrasound. A slim probe measures endometrial thickness. In women not taking HRT, a threshold of about 4 mm is widely used: a lining measuring 4 mm or less makes endometrial cancer very unlikely (negative predictive value above 99% in ACOG's assessment), and biopsy may not be needed straight away. A lining above that threshold, or one that can't be measured clearly, triggers tissue sampling.
- Endometrial biopsy. A fine tube passed through the cervix takes a sample of the lining. It's usually done in clinic in a couple of minutes. It commonly causes period-like cramping — ask what pain relief is offered and take it; you do not have to be stoic about this.
- Hysteroscopy. A thin camera looks directly inside the uterus, often with a biopsy or polyp removal at the same time. It's used when the ultrasound is unclear, when a biopsy fails or comes back insufficient, or when bleeding persists despite a "normal" result.
In the UK, unexplained postmenopausal bleeding in women aged 55 and over triggers an urgent suspected-cancer referral, with the aim of being seen within two weeks (NICE NG12). If someone tells you to come back in three months and see if it happens again, that is not the standard.
Does a normal ultrasound mean I'm in the clear?
Not if the bleeding continues. This is the most important paragraph on this page.
A thin endometrium on ultrasound makes cancer unlikely — it does not make it impossible. The 4 mm rule was validated for a single episode of bleeding, and it performs less well for some aggressive, non-oestrogen-driven tumour types (such as serous and clear-cell cancers) that can arise on a thin lining. ACOG is explicit that persistent or recurrent bleeding warrants tissue sampling regardless of what the scan showed.
So: if you were scanned, told the lining was thin, sent home — and you bleed again — go back. Say the words "the bleeding has recurred and I would like endometrial sampling." A reassuring scan does not close the question while the bleeding is still open.
What about bleeding while I'm on HRT?
This is where women are most often wrongly reassured, and also most often wrongly frightened. Both happen.
- Unscheduled bleeding in the first 3-6 months of starting or changing hormone therapy is common and usually expected. Roughly a third to a half of women on continuous combined HRT get some spotting early on, and it typically settles as the lining stabilises.
- Sequential (cyclical) HRT is designed to produce a predictable monthly withdrawal bleed. That bleed is planned. Bleeding at the wrong point in the cycle, or that becomes heavy or prolonged, is not.
- New bleeding after 6 months on a stable regimen, or bleeding that started early and simply never stopped, needs assessment. Full stop. HRT does not immunise you against polyps, hyperplasia or cancer — and the 4 mm ultrasound threshold is not reliable in HRT users, so the pathway usually goes straight to biopsy or hysteroscopy.
- Low-dose vaginal oestrogen for dryness is not a get-out clause either. It is very safe and barely absorbed, but if you're bleeding while using it, that bleeding still gets investigated.
Do not start, stop or change the dose of any hormone therapy on your own to see whether the bleeding settles — that muddies the picture and delays the answer. Report it to your prescriber and let them decide. If you want to arrive organised, the menopause doctor report can help you lay out dates, regimen and symptoms on one page.
What if it's discharge rather than blood?
After menopause, a persistent watery, pink, brown or blood-tinged discharge deserves exactly the same assessment as frank bleeding — it can be the earliest sign of endometrial cancer, and it is routinely mislabelled as "just atrophy" or "a bit of thrush." Do not reach for an over-the-counter thrush treatment and wait to see what happens; that is how weeks get lost on an undiagnosed symptom. A one-off patch of clear or white discharge with no other symptoms is usually nothing; anything watery-and-bloody, foul-smelling, or persistent is not something to sit on. (Before menopause, most brown, pink or white discharge is normal and cyclical — the context is genuinely different.)
When to see a doctor
Book an appointment for any bleeding or blood-tinged discharge that happens 12+ months after your last period — including a single spot, including bleeding only after sex, including bleeding that has already stopped. Ask specifically for a transvaginal ultrasound and, where indicated, endometrial sampling. Go back if the bleeding recurs after a normal scan.
Go now — same day, urgent care or emergency department — if you have:
- Heavy bleeding — soaking through a pad or tampon every hour for two hours or more
- Passing large clots
- Dizziness, light-headedness, fainting, breathlessness or a racing heart (signs of significant blood loss or anaemia)
- Severe pelvic or abdominal pain
- Fever with foul-smelling discharge
If you are dismissed. Women's bleeding is dismissed often enough that it's worth having a script. Try: "This is bleeding more than 12 months after my last period. Guidelines say that always needs investigating. I'd like an ultrasound and, if indicated, a biopsy — and I'd like the reason recorded in my notes if you're deciding not to refer." Asking for a decision to be documented is not rude. It changes outcomes.
Nothing on this page is a reason to feel foolish for going in. Nine women in ten walk out of that clinic with a benign explanation and a treatable one — dryness that responds to local oestrogen, a polyp that comes out in ten minutes. The tenth woman gets her cancer caught at a stage where it is usually cured. Both of those are good outcomes. The only bad outcome is the woman who waited.
Related reading: vaginal health after menopause, genitourinary syndrome of menopause, uterine fibroids, and our gynecologic health guide. Browse more in menopause and gynecologic health.
